Higher frequency of false-positive serum galactomannan tests among older subjects and the association with elevated serum immunoglobulin G levels.


Journal

Mycoses
ISSN: 1439-0507
Titre abrégé: Mycoses
Pays: Germany
ID NLM: 8805008

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 26 02 2019
revised: 29 05 2019
accepted: 02 06 2019
pubmed: 6 6 2019
medline: 18 12 2019
entrez: 6 6 2019
Statut: ppublish

Résumé

The incidence of false-positive serum galactomannan (GM) enzyme-linked immunosorbent assay test results has been scarcely examined among older subjects. Additionally, previous studies have highlighted the influence of serum immunoglobulin G (IgG) levels on GM test results. We hypothesised that age-related IgG level elevation might also be associated with false-positive GM test results in older subjects. This study aimed to examine the association between false-positive GM test results and age or serum IgG levels. We investigated the association between false-positive serum GM test results and age in 1071 healthy adult subjects. Then, we validated this association and further explored the correlation with serum IgG levels by retrospectively identifying 700 patients with newly diagnosed haematologic disorders without probable or proven invasive aspergillosis. Healthy subjects with false-positive GM test results were significantly older than those without false-positive results (P < 0.001). Among patients with haematologic disorders, IgG myeloma patients showed significantly higher false-positive rates (57/125 [45.6%]) than patients with other haematologic disorders (non-Hodgkin lymphoma: 48/315 [15.2%], myelodysplastic syndrome/aplastic anaemia: 19/141 [13.5%]; both P < 0.001) or other types of myeloma (IgA myeloma: 13/60 [21.7%], light chain myeloma: 9/52 [17.3%]; both P < 0.01). Furthermore, among non-multiple myeloma patients, advanced age and higher IgG level were also significantly associated with the high frequency of false-positive GM test results. False-positive serum GM test results were frequent among older subjects and patients with elevated serum IgG levels. These results suggested that age- and/or disease-related IgG level elevation could induce this phenomenon.

Sections du résumé

BACKGROUND BACKGROUND
The incidence of false-positive serum galactomannan (GM) enzyme-linked immunosorbent assay test results has been scarcely examined among older subjects. Additionally, previous studies have highlighted the influence of serum immunoglobulin G (IgG) levels on GM test results. We hypothesised that age-related IgG level elevation might also be associated with false-positive GM test results in older subjects.
OBJECTIVES OBJECTIVE
This study aimed to examine the association between false-positive GM test results and age or serum IgG levels.
PATIENTS/METHODS METHODS
We investigated the association between false-positive serum GM test results and age in 1071 healthy adult subjects. Then, we validated this association and further explored the correlation with serum IgG levels by retrospectively identifying 700 patients with newly diagnosed haematologic disorders without probable or proven invasive aspergillosis.
RESULTS RESULTS
Healthy subjects with false-positive GM test results were significantly older than those without false-positive results (P < 0.001). Among patients with haematologic disorders, IgG myeloma patients showed significantly higher false-positive rates (57/125 [45.6%]) than patients with other haematologic disorders (non-Hodgkin lymphoma: 48/315 [15.2%], myelodysplastic syndrome/aplastic anaemia: 19/141 [13.5%]; both P < 0.001) or other types of myeloma (IgA myeloma: 13/60 [21.7%], light chain myeloma: 9/52 [17.3%]; both P < 0.01). Furthermore, among non-multiple myeloma patients, advanced age and higher IgG level were also significantly associated with the high frequency of false-positive GM test results.
CONCLUSIONS CONCLUSIONS
False-positive serum GM test results were frequent among older subjects and patients with elevated serum IgG levels. These results suggested that age- and/or disease-related IgG level elevation could induce this phenomenon.

Identifiants

pubmed: 31165504
doi: 10.1111/myc.12951
doi:

Substances chimiques

Antigens, Fungal 0
Immunoglobulin G 0
Mannans 0
galactomannan 11078-30-1
Galactose X2RN3Q8DNE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

773-779

Informations de copyright

© 2019 Blackwell Verlag GmbH.

Auteurs

Yoshiaki Abe (Y)

Department of Internal Medicine, Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan.
Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.

Kentaro Narita (K)

Department of Internal Medicine, Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan.

Hiroki Kobayashi (H)

Department of Internal Medicine, Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan.

Akihiro Kitadate (A)

Department of Internal Medicine, Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan.

Masami Takeuchi (M)

Department of Internal Medicine, Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan.

Kosei Matsue (K)

Department of Internal Medicine, Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH